Journey Medical Corporation

NasdaqCM:DERM Stock Report

Market Cap: US$105.3m

Journey Medical Balance Sheet Health

Financial Health criteria checks 3/6

Journey Medical has a total shareholder equity of $10.9M and total debt of $21.0M, which brings its debt-to-equity ratio to 192.5%. Its total assets and total liabilities are $64.0M and $53.1M respectively.

Key information

192.5%

Debt to equity ratio

US$21.04m

Debt

Interest coverage ration/a
CashUS$22.46m
EquityUS$10.93m
Total liabilitiesUS$53.12m
Total assetsUS$64.04m

Recent financial health updates

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Recent updates

Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Oct 03
Journey Medical Corporation (NASDAQ:DERM) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Sep 14
Here's Why Journey Medical (NASDAQ:DERM) Has A Meaningful Debt Burden

Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

May 06
Does Journey Medical (NASDAQ:DERM) Have A Healthy Balance Sheet?

Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Mar 11
Journey Medical Corporation (NASDAQ:DERM) Not Doing Enough For Some Investors As Its Shares Slump 31%

Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Jan 18
Journey Medical Corporation's (NASDAQ:DERM) 33% Dip In Price Shows Sentiment Is Matching Revenues

Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Nov 10
Journey Medical Corporation's (NASDAQ:DERM) Price Is Right But Growth Is Lacking After Shares Rocket 26%

US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

May 12
US$12.00: That's What Analysts Think Journey Medical Corporation (NASDAQ:DERM) Is Worth After Its Latest Results

Financial Position Analysis

Short Term Liabilities: DERM's short term assets ($46.2M) exceed its short term liabilities ($33.3M).

Long Term Liabilities: DERM's short term assets ($46.2M) exceed its long term liabilities ($19.8M).


Debt to Equity History and Analysis

Debt Level: DERM has more cash than its total debt.

Reducing Debt: Insufficient data to determine if DERM's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DERM has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: DERM has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.9% each year


Discover healthy companies